Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Sell
49
GEHC Quote, Financials, Valuation and Earnings
Last price:
$79.79
Seasonality move
:
4.15%
Day range:
$79.58 - $81.81
52-week range:
$57.65 - $94.80
Dividend yield:
0.18%
P/E ratio:
16.49x
P/S ratio:
1.81x
P/B ratio:
3.64x
Volume:
2.3M
Avg. volume:
3.1M
1-year change:
-9.52%
Market cap:
$36.3B
Revenue:
$19.7B
EPS (TTM):
$4.84
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GEHC
GE Healthcare Technologies, Inc.
|
$5B | $0.99 | 4.81% | -19.22% | $92.00 |
|
ABT
Abbott Laboratories
|
$11B | $1.16 | 6.13% | 55.33% | $136.47 |
|
BSX
Boston Scientific Corp.
|
$5.2B | $0.80 | 11.57% | 76.14% | $124.41 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.6B | $2.12 | 16.15% | 10.92% | $606.43 |
|
MBOT
Microbot Medical, Inc.
|
$250K | -$0.08 | -- | -67.39% | $8.75 |
|
PEN
Penumbra, Inc.
|
$370.3M | $1.08 | 14.25% | 8.28% | $348.53 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GEHC
GE Healthcare Technologies, Inc.
|
$79.77 | $92.00 | $36.3B | 16.49x | $0.04 | 0.18% | 1.81x |
|
ABT
Abbott Laboratories
|
$107.42 | $136.47 | $186.8B | 29.01x | $0.63 | 2.23% | 4.24x |
|
BSX
Boston Scientific Corp.
|
$92.51 | $124.41 | $137.1B | 49.48x | $0.00 | 0% | 7.14x |
|
ISRG
Intuitive Surgical, Inc.
|
$523.99 | $606.43 | $185.8B | 66.49x | $0.00 | 0% | 18.88x |
|
MBOT
Microbot Medical, Inc.
|
$1.98 | $8.75 | $133M | -- | $0.00 | 0% | -- |
|
PEN
Penumbra, Inc.
|
$359.26 | $348.53 | $14.1B | 85.86x | $0.00 | 0% | 10.56x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GEHC
GE Healthcare Technologies, Inc.
|
51.81% | 1.017 | 31.2% | 0.85x |
|
ABT
Abbott Laboratories
|
20.25% | 0.321 | -- | 1.12x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.384 | 8.31% | 0.81x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.051 | -- | 3.42x |
|
MBOT
Microbot Medical, Inc.
|
1.14% | -0.419 | 0.45% | 27.34x |
|
PEN
Penumbra, Inc.
|
13.77% | -0.892 | 2.19% | 3.87x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GEHC
GE Healthcare Technologies, Inc.
|
$2B | $697M | 11.74% | 24.49% | 13.55% | $483M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.57% | 16.59% | 30.16% | $735.6M |
|
MBOT
Microbot Medical, Inc.
|
-$10K | -$3.9M | -44.68% | -45.11% | -- | -$3.9M |
|
PEN
Penumbra, Inc.
|
$238M | $48.8M | 11.35% | 13.4% | 13.77% | $42M |
GE Healthcare Technologies, Inc. vs. Competitors
-
Which has Higher Returns GEHC or ABT?
Abbott Laboratories has a net margin of 9.02% compared to GE Healthcare Technologies, Inc.'s net margin of 15.5%. GE Healthcare Technologies, Inc.'s return on equity of 24.49% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital GEHCGE Healthcare Technologies, Inc.38.73% $0.98 $21B ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About GEHC or ABT?
GE Healthcare Technologies, Inc. has a consensus price target of $92.00, signalling upside risk potential of 15.33%. On the other hand Abbott Laboratories has an analysts' consensus of $136.47 which suggests that it could grow by 27.23%. Given that Abbott Laboratories has higher upside potential than GE Healthcare Technologies, Inc., analysts believe Abbott Laboratories is more attractive than GE Healthcare Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GEHCGE Healthcare Technologies, Inc.10 6 1 ABTAbbott Laboratories15 8 0 -
Is GEHC or ABT More Risky?
GE Healthcare Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.721, suggesting its less volatile than the S&P 500 by 27.854%.
-
Which is a Better Dividend Stock GEHC or ABT?
GE Healthcare Technologies, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 0.18%. Abbott Laboratories offers a yield of 2.23% to investors and pays a quarterly dividend of $0.63 per share. GE Healthcare Technologies, Inc. pays 2.88% of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GEHC or ABT?
GE Healthcare Technologies, Inc. quarterly revenues are $5.1B, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. GE Healthcare Technologies, Inc.'s net income of $464M is lower than Abbott Laboratories's net income of $1.8B. Notably, GE Healthcare Technologies, Inc.'s price-to-earnings ratio is 16.49x while Abbott Laboratories's PE ratio is 29.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GE Healthcare Technologies, Inc. is 1.81x versus 4.24x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GEHCGE Healthcare Technologies, Inc.1.81x 16.49x $5.1B $464M ABTAbbott Laboratories4.24x 29.01x $11.5B $1.8B
-
Which has Higher Returns GEHC or BSX?
Boston Scientific Corp. has a net margin of 9.02% compared to GE Healthcare Technologies, Inc.'s net margin of 14.91%. GE Healthcare Technologies, Inc.'s return on equity of 24.49% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital GEHCGE Healthcare Technologies, Inc.38.73% $0.98 $21B BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About GEHC or BSX?
GE Healthcare Technologies, Inc. has a consensus price target of $92.00, signalling upside risk potential of 15.33%. On the other hand Boston Scientific Corp. has an analysts' consensus of $124.41 which suggests that it could grow by 34.48%. Given that Boston Scientific Corp. has higher upside potential than GE Healthcare Technologies, Inc., analysts believe Boston Scientific Corp. is more attractive than GE Healthcare Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GEHCGE Healthcare Technologies, Inc.10 6 1 BSXBoston Scientific Corp.26 1 0 -
Is GEHC or BSX More Risky?
GE Healthcare Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.670, suggesting its less volatile than the S&P 500 by 33.029%.
-
Which is a Better Dividend Stock GEHC or BSX?
GE Healthcare Technologies, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 0.18%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GE Healthcare Technologies, Inc. pays 2.88% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. GE Healthcare Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GEHC or BSX?
GE Healthcare Technologies, Inc. quarterly revenues are $5.1B, which are larger than Boston Scientific Corp. quarterly revenues of $5.1B. GE Healthcare Technologies, Inc.'s net income of $464M is lower than Boston Scientific Corp.'s net income of $755M. Notably, GE Healthcare Technologies, Inc.'s price-to-earnings ratio is 16.49x while Boston Scientific Corp.'s PE ratio is 49.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GE Healthcare Technologies, Inc. is 1.81x versus 7.14x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GEHCGE Healthcare Technologies, Inc.1.81x 16.49x $5.1B $464M BSXBoston Scientific Corp.7.14x 49.48x $5.1B $755M
-
Which has Higher Returns GEHC or ISRG?
Intuitive Surgical, Inc. has a net margin of 9.02% compared to GE Healthcare Technologies, Inc.'s net margin of 27.89%. GE Healthcare Technologies, Inc.'s return on equity of 24.49% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital GEHCGE Healthcare Technologies, Inc.38.73% $0.98 $21B ISRGIntuitive Surgical, Inc.66.56% $2.21 $17.9B -
What do Analysts Say About GEHC or ISRG?
GE Healthcare Technologies, Inc. has a consensus price target of $92.00, signalling upside risk potential of 15.33%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $606.43 which suggests that it could grow by 15.73%. Given that Intuitive Surgical, Inc. has higher upside potential than GE Healthcare Technologies, Inc., analysts believe Intuitive Surgical, Inc. is more attractive than GE Healthcare Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GEHCGE Healthcare Technologies, Inc.10 6 1 ISRGIntuitive Surgical, Inc.14 11 1 -
Is GEHC or ISRG More Risky?
GE Healthcare Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.867%.
-
Which is a Better Dividend Stock GEHC or ISRG?
GE Healthcare Technologies, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 0.18%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GE Healthcare Technologies, Inc. pays 2.88% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. GE Healthcare Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GEHC or ISRG?
GE Healthcare Technologies, Inc. quarterly revenues are $5.1B, which are larger than Intuitive Surgical, Inc. quarterly revenues of $2.9B. GE Healthcare Technologies, Inc.'s net income of $464M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, GE Healthcare Technologies, Inc.'s price-to-earnings ratio is 16.49x while Intuitive Surgical, Inc.'s PE ratio is 66.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GE Healthcare Technologies, Inc. is 1.81x versus 18.88x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GEHCGE Healthcare Technologies, Inc.1.81x 16.49x $5.1B $464M ISRGIntuitive Surgical, Inc.18.88x 66.49x $2.9B $799.5M
-
Which has Higher Returns GEHC or MBOT?
Microbot Medical, Inc. has a net margin of 9.02% compared to GE Healthcare Technologies, Inc.'s net margin of --. GE Healthcare Technologies, Inc.'s return on equity of 24.49% beat Microbot Medical, Inc.'s return on equity of -45.11%.
Company Gross Margin Earnings Per Share Invested Capital GEHCGE Healthcare Technologies, Inc.38.73% $0.98 $21B MBOTMicrobot Medical, Inc.-- -$0.07 $79.1M -
What do Analysts Say About GEHC or MBOT?
GE Healthcare Technologies, Inc. has a consensus price target of $92.00, signalling upside risk potential of 15.33%. On the other hand Microbot Medical, Inc. has an analysts' consensus of $8.75 which suggests that it could grow by 341.92%. Given that Microbot Medical, Inc. has higher upside potential than GE Healthcare Technologies, Inc., analysts believe Microbot Medical, Inc. is more attractive than GE Healthcare Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GEHCGE Healthcare Technologies, Inc.10 6 1 MBOTMicrobot Medical, Inc.2 0 0 -
Is GEHC or MBOT More Risky?
GE Healthcare Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Microbot Medical, Inc. has a beta of 1.231, suggesting its more volatile than the S&P 500 by 23.071%.
-
Which is a Better Dividend Stock GEHC or MBOT?
GE Healthcare Technologies, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 0.18%. Microbot Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GE Healthcare Technologies, Inc. pays 2.88% of its earnings as a dividend. Microbot Medical, Inc. pays out -- of its earnings as a dividend. GE Healthcare Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GEHC or MBOT?
GE Healthcare Technologies, Inc. quarterly revenues are $5.1B, which are larger than Microbot Medical, Inc. quarterly revenues of --. GE Healthcare Technologies, Inc.'s net income of $464M is higher than Microbot Medical, Inc.'s net income of -$3.6M. Notably, GE Healthcare Technologies, Inc.'s price-to-earnings ratio is 16.49x while Microbot Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GE Healthcare Technologies, Inc. is 1.81x versus -- for Microbot Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GEHCGE Healthcare Technologies, Inc.1.81x 16.49x $5.1B $464M MBOTMicrobot Medical, Inc.-- -- -- -$3.6M
-
Which has Higher Returns GEHC or PEN?
Penumbra, Inc. has a net margin of 9.02% compared to GE Healthcare Technologies, Inc.'s net margin of 12.93%. GE Healthcare Technologies, Inc.'s return on equity of 24.49% beat Penumbra, Inc.'s return on equity of 13.4%.
Company Gross Margin Earnings Per Share Invested Capital GEHCGE Healthcare Technologies, Inc.38.73% $0.98 $21B PENPenumbra, Inc.67.1% $1.17 $1.6B -
What do Analysts Say About GEHC or PEN?
GE Healthcare Technologies, Inc. has a consensus price target of $92.00, signalling upside risk potential of 15.33%. On the other hand Penumbra, Inc. has an analysts' consensus of $348.53 which suggests that it could fall by -2.99%. Given that GE Healthcare Technologies, Inc. has higher upside potential than Penumbra, Inc., analysts believe GE Healthcare Technologies, Inc. is more attractive than Penumbra, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GEHCGE Healthcare Technologies, Inc.10 6 1 PENPenumbra, Inc.2 13 1 -
Is GEHC or PEN More Risky?
GE Healthcare Technologies, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Penumbra, Inc. has a beta of 0.714, suggesting its less volatile than the S&P 500 by 28.599%.
-
Which is a Better Dividend Stock GEHC or PEN?
GE Healthcare Technologies, Inc. has a quarterly dividend of $0.04 per share corresponding to a yield of 0.18%. Penumbra, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GE Healthcare Technologies, Inc. pays 2.88% of its earnings as a dividend. Penumbra, Inc. pays out -- of its earnings as a dividend. GE Healthcare Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GEHC or PEN?
GE Healthcare Technologies, Inc. quarterly revenues are $5.1B, which are larger than Penumbra, Inc. quarterly revenues of $354.7M. GE Healthcare Technologies, Inc.'s net income of $464M is higher than Penumbra, Inc.'s net income of $45.9M. Notably, GE Healthcare Technologies, Inc.'s price-to-earnings ratio is 16.49x while Penumbra, Inc.'s PE ratio is 85.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GE Healthcare Technologies, Inc. is 1.81x versus 10.56x for Penumbra, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GEHCGE Healthcare Technologies, Inc.1.81x 16.49x $5.1B $464M PENPenumbra, Inc.10.56x 85.86x $354.7M $45.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 24
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
64
BNR alert for Jan 24
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Sell
19
APGE alert for Jan 24
Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.
